These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15667966)

  • 1. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence.
    Singh AK; Grigsby PW; Rader JS; Mutch DG; Powell MA
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):450-5. PubMed ID: 15667966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of paraaortic lymph nodes metastases in carcinoma of the cervix: analysis of treatment outcome.
    Plesinac-Karapandzic V; Zoranovic S; Tomasevic A; Radonjic M; Rakovic B; Nikitivic M; Cikaric S
    J BUON; 2006; 11(3):299-303. PubMed ID: 17309153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
    Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphatic metastasis in patients with invasive cervical carcinoma after initial treatment].
    Lou HM; Li Q
    Ai Zheng; 2007 Nov; 26(11):1248-51. PubMed ID: 17991327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
    Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
    J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
    Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review.
    Ring KL; Young JL; Dunlap NE; Andersen WA; Schneider BF
    Am J Obstet Gynecol; 2009 Jul; 201(1):109.e1-6. PubMed ID: 19398095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
    Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin.
    Wun T; Law L; Harvey D; Sieracki B; Scudder SA; Ryu JK
    Cancer; 2003 Oct; 98(7):1514-20. PubMed ID: 14508840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
    Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.